1-azaspirocycle compound, and preparation method and applications thereof
A technology for azaspirocyclic compounds, which is applied in the field of azaspirocyclic compounds and their preparation, and can solve the problem of high concentration of LPA
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0120] Compound 1: Preparation of tert-butyl 3,5-dichlorobenzyl 6-(4-sulfamoylbenzoyl)-2,6-diazaspiro[3.3]heptane-2-carboxylate.
[0121]
[0122]
[0123] Synthesis according to the above route, including the following steps:
[0124] (1) Preparation of methyl 1-benzoylazetidine-3-carboxylate (compound 1-1).
[0125]Get a 250mL single-necked bottle, add azetidine-3-carboxylate methyl ester (10g, 86.9mmol), dissolve in DCM (100mL), add triethylamine (14.5mL, 104.2mmol, 1.2 equivalents), place in 0 ℃, slowly added BzCl (11.1 mL, 95.6 mmol, 1.1 equiv), stirred at room temperature overnight, followed by TLC monitoring. After completion of the reaction, cool to room temperature, add saturated NaHCO 3 The solution was extracted with DCM, washed with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and passed through a column to obtain 18.5 g of a yellow liquid with a yield of 96.8%. ESI-MS m / z: 220.1(M+H) + .
[0126] (2) Preparation of dimethyl 1-benzoy...
Embodiment 2
[0149] Compound 2: Preparation of 4-(trifluoromethoxy)benzyl-6-(4-sulfamoylbenzoyl)-2,6-diazaspiro[3.3]heptane-2-carboxylate.
[0150]
[0151] Synthesis according to the above route, including the following steps:
[0152] The compound 4-trifluoromethoxybenzyl alcohol (50mg, 0.26mmol, 1eq), N,N'-carbonyldiimidazole (51mg, 0.31mmol, 1.2eq) was dissolved in DMF in a 10mL single-necked bottle, and stirred at room temperature for 2h. Compound 1-9 was dissolved in DMF, TEA (46 μL, 0.31 mmol, 1.2 eq) was added, the reaction solution was added, and stirred at room temperature. TLC tracking monitoring. Spin off most of the solvent with an oil pump, add EA and water, wash with saturated brine, dry over anhydrous sodium sulfate, and pass through a column (DCM:acetone=3:1). 45 mg of white powder was obtained, namely Compound 2.
[0153] The characterization data of this compound 2 are: 1 H NMR (400MHz, DMSO-d 6 ,δ ppm ): 7.89(d, J=6.4Hz, 2H), 7.78(d, J=6.4Hz, 2H), 7.49(d, J=9.2...
Embodiment 3
[0155] Compound 3: Preparation of 3,5-dichlorobenzyl-2-(4-sulfamoylbenzoyl)-2,7-diazaspiro[3.5]nonane-7-carboxylate.
[0156]
[0157]
[0158] Synthesis according to the above route, including the following steps:
[0159] (1) Preparation of methyl 1-benzoylpiperidine-4-carboxylate (compound 2-1).
[0160] Take a 100mL single-necked bottle, add p-methylpiperidine (5.1g, 35.6mmol), dissolve in DCM (50mL), add triethylamine (6mL, 42.7mmo, 11.2 equivalents), place at 0°C, and slowly add BzCl (4.5mL, 39.2mmol, 1.1eq), stirred at room temperature overnight, followed by TLC monitoring. After completion of the reaction, cool to room temperature, add saturated NaHCO 3 The solution was extracted with DCM, washed with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and passed through a column to obtain 8.6 g of a yellow liquid with a yield of 98%. ESI-MS m / z: 248.1(M+H) + .
[0161] (2) Preparation of methyl 1-benzoylpiperidine-4,4-dicarboxylate (compound 2...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


